Targeting AKT/PKB to improve treatment outcomes for solid tumors

M Iida, PM Harari, DL Wheeler, M Toulany - … Research/Fundamental and …, 2020 - Elsevier
The serine/threonine kinase AKT, also known as protein kinase B (PKB), is the major
substrate to phosphoinositide 3-kinase (PI3K) and consists of three paralogs: AKT1 (PKBα) …
被引用次数：76 相关文章

[引用][C] Targeting AKT/PKB to improve treatment outcomes for solid tumors

M Iida, PM Harari, DL Wheeler, M Toulany - … Research/Fundamental and …, 2020 - cir.nii.ac.jp
Targeting AKT/PKB to improve treatment outcomes for solid tumors | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

[引用][C] Targeting AKT/PKB to improve treatment outcomes for solid tumors

M Iida, PM Harari, DL Wheeler… - Mutation Research …, 2020 - ub01.uni-tuebingen.de
Targeting AKT/PKB to improve treatment outcomes for solid tumors Targeting AKT/PKB to
improve treatment outcomes for solid tumors DSpace Repositorium (Manakin basiert) Einloggen …

[引用][C] Targeting AKT/PKB to improve treatment outcomes for solid tumors

M Iida, PM Harari, DL Wheeler… - Mutation Research …, 2020 - tobias-lib.ub.uni-tuebingen.de
Targeting AKT/PKB to improve treatment outcomes for solid tumors Targeting AKT/PKB to
improve treatment outcomes for solid tumors DSpace Repositorium (Manakin basiert) Einloggen …

Targeting AKT/PKB to improve treatment outcomes for solid tumors

M Iida, PM Harari, DL Wheeler… - Mutation Research …, 2020 - ui.adsabs.harvard.edu
The serine/threonine kinase AKT, also known as protein kinase B (PKB), is the major
substrate to phosphoinositide 3-kinase (PI3K) and consists of three paralogs: AKT1 (PKBα) …

Targeting AKT/PKB to improve treatment outcomes for solid tumors.

M Iida, PM Harari, DL Wheeler, M Toulany - Mutation Research, 2020 - europepmc.org
The serine/threonine kinase AKT, also known as protein kinase B (PKB), is the major
substrate to phosphoinositide 3-kinase (PI3K) and consists of three paralogs: AKT1 (PKBα) …
[HTML] nih.gov

[HTML][HTML] Targeting AKT/PKB to improve treatment outcomes for solid tumors

M Iida, PM Harari, DL Wheeler, M Toulany - Mutation research, 2020 - ncbi.nlm.nih.gov
The serine/threonine kinase AKT, also known as protein kinase B (PKB), is the major
substrate to phosphoinositide 3-kinase (PI3K) and consists of three paralogs: AKT1 (PKBα) …

Targeting AKT/PKB to improve treatment outcomes for solid tumors

M Iida, PM Harari, DL Wheeler… - Mutation …, 2020 - pubmed.ncbi.nlm.nih.gov
The serine/threonine kinase AKT, also known as protein kinase B (PKB), is the major
substrate to phosphoinositide 3-kinase (PI3K) and consists of three paralogs: AKT1 (PKBα) …

Targeting AKT/PKB to improve treatment outcomes for solid tumors.

M Iida, PM Harari, DL Wheeler, M Toulany - Mutation Research, 2020 - europepmc.org
The serine/threonine kinase AKT, also known as protein kinase B (PKB), is the major
substrate to phosphoinositide 3-kinase (PI3K) and consists of three paralogs: AKT1 (PKBα) …